Wolverine Trading
GNPX icon

Wolverine Trading’s Genprex GNPX Stock Holding History

Wolverine Trading’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– -$23K – 4962
2022
Q1 		– Hold
0
– – – 5226
2021
Q4 		– Sell
-1
Closed -$71K – 6246
2021
Q3 		$71K Hold
1
– – ﹤0.01% 5915
2021
Q2 		$83K Hold
1
– – ﹤0.01% 5485
2021
Q1 		$94K Buy
+1
New +$220K ﹤0.01% 5459
2020
Q4 		– Hold
0
– – – 4507

Other funds holding GNPX

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Cypress Capital Franklin, Tennessee $370M AUM 16.36% 1-Year Est. Return
VCP
Verus Capital Partners Scottsdale, Arizona $1.46B AUM 27.29% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wolverine Trading's GNPX Position: Q4 2021 in Review

Wolverine Trading sold out of Genprex (GNPX) in Q4 2021, closing a stake of 1 share — an estimated $83.4K sold.

Wolverine Trading first reported a position in GNPX in Q4 2020 and held it in 3 quarters. The position peaked at $116K in Q4 2020. 25 funds tracked by Wall St. Rank hold GNPX as of Q4 2021.

  • Wolverine Trading reported no remaining Genprex position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 1 Genprex share in Q4 2021, an estimated $83.4K.
  • Wolverine Trading first reported a position in Genprex in Q4 2020 and held it in 3 quarters.
  • Wolverine Trading's Genprex position peaked at $116K in Q4 2020.
  • 25 funds tracked by Wall St. Rank held Genprex as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.